Evidence actions
Exact observation fact_0fr9q7j
What is Bristol-Myers Squibb doing now, what supports the move, and where does the evidence end? Start with price, then add history and method.
BMY is higher by +2.35% at 67.01 USD.
52-week range: 42.52 to 68.64.
Bristol-Myers Squibb is covered as a listed equity. Price, chart, seasonality, attributed news, comparable assets, and research actions remain in scope. Company-only datasets stay off when they do not describe this instrument.
The current CBOE coverage set does not include this instrument.
Issuer fundamentals and the call brief are linked to the mapped company identifier.
Listed equity or fund distributions are included when the upstream record is available.
SEC filings, ownership context, and applicable public disclosures share one chapter.
Published company earnings dates can appear on the chart when present.
Exact observation fact_0fr9q7j
Exact observation fact_178jvvh
Exact observation fact_1osc1mv
Exact observation fact_18efelb
Exact observation fact_0ni0wdt
No recent wires mention this symbol.
The desk checks delayed market quotes every 30 seconds through . The quote payload separates upstream observation time from edge retrieval time. The chart and the 52-week range read from Yahoo's chart endpoint; the news rail reads Yahoo's search/news endpoint filtered to the last 24 hours.
Every number on this page carries a hover tooltip. No cookies, no signup walls. The page is one HTML file plus a few client-side fetches.
Data is informational; not investment advice.